• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期系统性硬化症随访一年中雷诺现象及其对日常生活活动的影响。

Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.

作者信息

Sandqvist G, Wollmer P, Scheja A, Wildt M, Hesselstrand R

机构信息

a Department of Clinical Sciences Lund, Section of Rheumatology , Lund University, Skåne University Hospital , Lund , Sweden.

b Department of Translational Medicine , Lund University , Lund , Sweden.

出版信息

Scand J Rheumatol. 2018 May;47(3):206-209. doi: 10.1080/03009742.2017.1350745. Epub 2017 Aug 13.

DOI:10.1080/03009742.2017.1350745
PMID:28803485
Abstract

OBJECTIVE

To investigate Raynaud's phenomenon (RP) and its impact on daily life activities during 1 year of follow-up in early systemic sclerosis (SSc).

METHOD

Fourteen SSc patients with a median disease duration of 2 years were enrolled in the study. Every 7 weeks the patients completed a 7 day diary documenting the frequency and duration of RP attacks, the activity causing the attack, and how they handled the attack. The patients also recorded in the diary daily self-assessments of the difficulties with RP, using a 0-10 ordinal scale according to the Raynaud's Condition Score.

RESULTS

Ninety-eight RP weekly diaries were analysed. The median number of RP attacks varied between six and nine per week, and the median score reflecting the difficulty associated with the attacks varied between 2.0 and 2.9. No difference was found in the number of attacks or the difficulties associated with them between winter, spring, and autumn. Fewer attacks and less difficulty were reported in August than in any of the other documented weeks (p < 0.05). In all diaries, all patients reported RP attacks associated with domestic activities. The use of heating devices varied during the follow-up. In February, all patients except one used such devices, while about half of the group used devices during the rest of the year.

CONCLUSIONS

Difficulties resulting from RP are present and disabling all year round, which underscore the importance of intense vasoactive therapy and non-pharmacological strategies throughout the year.

摘要

目的

调查早期系统性硬化症(SSc)患者在1年随访期间的雷诺现象(RP)及其对日常生活活动的影响。

方法

14例疾病持续时间中位数为2年的SSc患者纳入本研究。每7周,患者完成一份为期7天的日记,记录RP发作的频率和持续时间、引发发作的活动以及他们如何应对发作。患者还根据雷诺病情评分,使用0至10的序数量表在日记中记录每日对RP相关困难的自我评估。

结果

分析了98份RP每周日记。RP发作的中位数为每周6至9次,反映发作相关困难的中位数评分在2.0至2.9之间。冬季、春季和秋季的发作次数或与之相关的困难没有差异。8月报告的发作次数和困难程度均低于其他任何记录周(p<0.05)。在所有日记中,所有患者均报告了与家务活动相关的RP发作。随访期间加热设备的使用情况有所不同。2月,除1名患者外,所有患者都使用了此类设备,而在一年中的其他时间,约一半患者使用了设备。

结论

RP导致的困难全年存在且使人丧失能力,这突出了全年强化血管活性治疗和非药物策略的重要性。

相似文献

1
Raynaud's phenomenon and its impact on activities in daily life during one year of follow-up in early systemic sclerosis.早期系统性硬化症随访一年中雷诺现象及其对日常生活活动的影响。
Scand J Rheumatol. 2018 May;47(3):206-209. doi: 10.1080/03009742.2017.1350745. Epub 2017 Aug 13.
2
Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.测量硬皮病和雷诺现象患者的疾病活动度和功能状态。
Arthritis Rheum. 2002 Sep;46(9):2410-20. doi: 10.1002/art.10486.
3
Seasonal variation of Raynaud's phenomenon secondary to systemic sclerosis.
J Rheumatol. 1999 Aug;26(8):1734-7.
4
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.口服伊洛前列素治疗系统性硬化症继发雷诺现象患者:一项多中心、安慰剂对照、双盲研究。
Arthritis Rheum. 1998 Apr;41(4):670-7. doi: 10.1002/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I.
5
Evolving Symptom Characteristics of Raynaud's Phenomenon in Systemic Sclerosis and Their Association With Physician and Patient-Reported Assessments of Disease Severity.雷诺现象在系统性硬化症中的症状特征演变及其与医生和患者报告的疾病严重程度评估的关系。
Arthritis Care Res (Hoboken). 2019 Aug;71(8):1119-1126. doi: 10.1002/acr.23729. Epub 2019 Jul 3.
6
Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.口服伊洛前列素治疗系统性硬化症继发雷诺现象:一项多中心、安慰剂对照、剂量比较研究。
Br J Rheumatol. 1998 Sep;37(9):952-60. doi: 10.1093/rheumatology/37.9.952.
7
Efficacy and Safety of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis: A Randomized, Placebo-Controlled, Phase II Study.塞来昔帕用于治疗系统性硬化症相关雷诺现象的成人患者的疗效和安全性:一项随机、安慰剂对照、II 期研究。
Arthritis Rheumatol. 2017 Dec;69(12):2370-2379. doi: 10.1002/art.40242.
8
Successful treatment of patients with severe secondary Raynaud's phenomenon with the endothelin receptor antagonist bosentan.内皮素受体拮抗剂波生坦成功治疗重度继发性雷诺现象患者。
Rheumatology (Oxford). 2006 Oct;45 Suppl 3:iii45-8. doi: 10.1093/rheumatology/kel290.
9
Efficacy of cilostazol for the treatment of Raynaud's phenomenon in systemic sclerosis patients.西洛他唑治疗系统性硬化症患者雷诺现象的疗效。
Clin Exp Med. 2016 Aug;16(3):407-12. doi: 10.1007/s10238-015-0370-5. Epub 2015 Jun 19.
10
Beneficial effect of botulinum toxin A on Raynaud's phenomenon in Japanese patients with systemic sclerosis: A prospective, case series study.A型肉毒杆菌毒素对日本系统性硬化症患者雷诺现象的有益作用:一项前瞻性病例系列研究。
J Dermatol. 2016 Jan;43(1):56-62. doi: 10.1111/1346-8138.13030. Epub 2015 Jul 15.

引用本文的文献

1
Physical activity, sedentary behaviour and health-related quality of life in 929 women with primary Raynaud's phenomenon.929例原发性雷诺现象女性的体力活动、久坐行为与健康相关生活质量
Clin Rheumatol. 2025 Apr 17. doi: 10.1007/s10067-025-07416-w.
2
Analysis of Hand Function, Upper Limb Disability, and Its Relationship with Peripheral Vascular Alterations in Raynaud's Phenomenon.雷诺现象中手部功能、上肢残疾及其与外周血管改变的关系分析
Diagnostics (Basel). 2023 Dec 30;14(1):93. doi: 10.3390/diagnostics14010093.
3
Management of Raynaud's phenomenon in systemic sclerosis-a practical approach.
系统性硬化症中雷诺现象的管理——一种实用方法
J Scleroderma Relat Disord. 2019 Jun;4(2):102-110. doi: 10.1177/2397198318823951. Epub 2019 Jan 28.
4
Raynaud's phenomenon.雷诺现象
J Scleroderma Relat Disord. 2019 Jun;4(2):89-101. doi: 10.1177/2397198319826467. Epub 2019 Feb 13.
5
Room for improvement in non-pharmacological systemic sclerosis care? - a cross-sectional online survey of 650 patients.非药物性系统性硬化症护理是否有改进空间?——对650名患者的横断面在线调查
BMC Rheumatol. 2020 Jul 31;4:43. doi: 10.1186/s41927-020-00142-7. eCollection 2020.
6
Raynaud's phenomenon-an update on diagnosis, classification and management.雷诺现象:诊断、分类和管理的最新进展。
Clin Rheumatol. 2019 Dec;38(12):3317-3330. doi: 10.1007/s10067-019-04745-5. Epub 2019 Aug 16.